Second Chance for Moms Act

H.R. 796

This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

Want to find out the status of this bill? Get the Pocket Congress app.

Open in the Pocket Congress app
Download on the App Store

Scan to open this page in Pocket Congress